Role of Epithelium-Derived Cytokines in Atopic Dermatitis and Psoriasis: Evidence and Therapeutic Perspectives
- PMID: 34944487
- PMCID: PMC8699296
- DOI: 10.3390/biom11121843
Role of Epithelium-Derived Cytokines in Atopic Dermatitis and Psoriasis: Evidence and Therapeutic Perspectives
Abstract
Atopic dermatitis and psoriasis are two of the most common chronic skin conditions. Current target therapies represent viable and safe solutions for the most severe cases of these two dermatoses but, presently, several limitations exist in terms of efficacy and side effects. A new class of products, epithelium-derived cytokines (TSLP, IL-25, IL-33), show an increasing potential for use in target therapy for these patients, and demonstrate a direct link between a generalized inflammatory and oxidative stress status and the human skin. A review was conducted to better understand their role in the aforementioned conditions. Of these three molecules, TSLP led has been most often considered in studies regarding target therapies, and most of the results in the literature are related to this cytokine. These three cytokines share common stimuli and are linked to each other in both acute and chronic phases of these diseases, and have been challenged as target therapies or biomarkers of disease activity. The results lead to the conclusion that epithelium-derived cytokines could represent a therapeutic opportunity for these patients, especially in itch control. Furthermore, they might work better when paired together with currently available therapies or in combination with in-development treatments. Further studies are needed in order to verify the efficacy and safety of the biologic treatments currently under development.
Keywords: TSLP; atopic dermatitis; biological therapy; epithelium derived cytokine; inflammation; interleukin 25; interleukin 33; oxidative stress; psoriasis; skin.
Conflict of interest statement
The authors declare no conflict of interest.
Figures


Similar articles
-
A Narrative Review of the IL-18 and IL-37 Implications in the Pathogenesis of Atopic Dermatitis and Psoriasis: Prospective Treatment Targets.Int J Mol Sci. 2024 Aug 2;25(15):8437. doi: 10.3390/ijms25158437. Int J Mol Sci. 2024. PMID: 39126010 Free PMC article. Review.
-
Cytokine and anti-cytokine therapies for psoriasis and atopic dermatitis.BioDrugs. 2006;20(2):93-103. doi: 10.2165/00063030-200620020-00004. BioDrugs. 2006. PMID: 16626167 Review.
-
Th2 Modulation of Transient Receptor Potential Channels: An Unmet Therapeutic Intervention for Atopic Dermatitis.Front Immunol. 2021 Jun 30;12:696784. doi: 10.3389/fimmu.2021.696784. eCollection 2021. Front Immunol. 2021. PMID: 34276687 Free PMC article. Review.
-
Atopic dermatitis and psoriasis: two different immune diseases or one spectrum?Curr Opin Immunol. 2017 Oct;48:68-73. doi: 10.1016/j.coi.2017.08.008. Epub 2017 Sep 1. Curr Opin Immunol. 2017. PMID: 28869867 Review.
-
Biologics and Small Molecule Agents in Allergic and Immunologic Skin Diseases.Curr Allergy Asthma Rep. 2018 Aug 31;18(10):55. doi: 10.1007/s11882-018-0804-8. Curr Allergy Asthma Rep. 2018. PMID: 30171358 Review.
Cited by
-
Insight Into Biological Targets and Molecular Mechanisms in the Treatment of Arsenic-Related Dermatitis With Vitamin A via Integrated in silico Approach.Front Nutr. 2022 May 23;9:847320. doi: 10.3389/fnut.2022.847320. eCollection 2022. Front Nutr. 2022. PMID: 35685889 Free PMC article.
-
Role of antioxidants supplementation in the treatment of atopic dermatitis: a critical narrative review.Front Nutr. 2024 Jun 12;11:1393673. doi: 10.3389/fnut.2024.1393673. eCollection 2024. Front Nutr. 2024. PMID: 38933878 Free PMC article. Review.
-
Oxidative stress products and managements in atopic dermatitis.Front Med (Lausanne). 2025 May 9;12:1538194. doi: 10.3389/fmed.2025.1538194. eCollection 2025. Front Med (Lausanne). 2025. PMID: 40417699 Free PMC article. Review.
-
Molybdenum Nanoparticles Alleviate MC903-Induced Atopic Dermatitis-Like Symptoms in Mice by Modulating the ROS-Mediated NF-κB and Nrf2 /HO-1 Signaling Pathways.Int J Nanomedicine. 2024 Aug 27;19:8779-8796. doi: 10.2147/IJN.S472999. eCollection 2024. Int J Nanomedicine. 2024. PMID: 39220192 Free PMC article.
-
Oxidative Stress and Phototherapy in Atopic Dermatitis: Mechanisms, Role, and Future Perspectives.Biomolecules. 2022 Dec 19;12(12):1904. doi: 10.3390/biom12121904. Biomolecules. 2022. PMID: 36551332 Free PMC article. Review.
References
-
- Roduit C., Frei R., Depner M., Karvonen A.M., Renz H., Braun-Fahrländer C., Schmausser-Hechfellner E., Pekkanen J., Riedler J., Dalphin J.-C., et al. Phenotypes of Atopic Dermatitis Depending on the Timing of Onset and Progression in Childhood. JAMA Pediatr. 2017;171:655–662. doi: 10.1001/jamapediatrics.2017.0556. - DOI - PMC - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials